Overview

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Status:
Completed

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

This study is an evaluation of the precision and sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Planar Imaging

Phase:

Phase 2

Details

Lead Sponsor:

Navidea Biopharmaceuticals